Seeking Alpha

Tekmira +4% on takeover rumors; Shire, Glaxo said to have interest

  • Tekmira Pharma (NASDAQ:TKMR) +4.2% AH following a Daily Mail story suggesting it is a takeover candidate, after shares have nearly doubled in the past month thanks to attention over its experimental treatment for the deadly ebola virus.
  • Rumors suggest interested parties could include Shire (NASDAQ:SHPG) and GlaxoSmithKline (NYSE:GSK); the report suggests the recent premium paid for  InterMune could put a valuation of at least $40/share on TKMR.
From other sites
Comments (9)
  • john812
    , contributor
    Comments (30) | Send Message
     
    I will take that.
    27 Aug, 07:05 PM Reply Like
  • cautionsvestor
    , contributor
    Comments (14) | Send Message
     
    The daily mail said the same thing about $ARIA couple of months ago :)
    27 Aug, 07:12 PM Reply Like
  • BioDoubt
    , contributor
    Comments (16) | Send Message
     
    And countless others as well. They are always wrong, but yet retail traders bid it up every single time.
    27 Aug, 07:48 PM Reply Like
  • flyerguy1300
    , contributor
    Comments (301) | Send Message
     
    I'll take the takeover more profit for me :)
    27 Aug, 07:41 PM Reply Like
  • Amerc96
    , contributor
    Comments (8) | Send Message
     
    Statistically, shorting into the teeth of these kind of rumors has been a winning play......just sayin....
    27 Aug, 07:42 PM Reply Like
  • shakazoid
    , contributor
    Comments (179) | Send Message
     
    A new sucker is born everyday for Daily mail. It is the Fox news of M&A
    27 Aug, 07:56 PM Reply Like
  • temac
    , contributor
    Comment (1) | Send Message
     
    Temack50, I truly enjoyed the write up i'm long tkmr and believe in their progress. I currently work in molecular, anti-body and peptide imaging for diagnostic and therapeutic treatments i hope they succeed.
    27 Aug, 09:05 PM Reply Like
  • patfactorx
    , contributor
    Comments (41) | Send Message
     
    Fast money is fast money
    28 Aug, 01:03 AM Reply Like
  • great article
    , contributor
    Comments (3) | Send Message
     
    As long as ebola continues to claim lives, TKMR will continue to surge. It's likely to see $32 short term before it's said and done, and unless there is a buyout as rumored.
    30 Aug, 08:57 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector